Skip to main content
. 2025 Jul 29;26:423. doi: 10.1186/s12882-025-04359-x

Table 2.

Clinical outcomes

Underweight
(n = 660)
Normal weight
(n = 3936)
Overweight
(n = 1921)
Obesity
(n = 2613)
P-value
DGF 21 (3.2%) 170 (4.3%) 63 (3.3%) 120 (4.6%) 0.079
Acute rejection 132 (20.0%) 706 (17.9%) 333 (17.3%) 530 (20.3%) 0.031
de novo DSA 61 (9.2%) 375 (9.5%) 217 (11.3%) 239 (9.1%) 0.082
Death-censored allograft loss 18 (2.7%) 101 (2.6%) 55 (2.9%) 96 (3.7%) 0.073
Cardiovascular events 48 (7.3%) 228 (5.8%) 128 (6.7%) 163 (6.2%) 0.371
All-cause mortality 15 (2.3%) 83 (2.1%) 41 (2.1%) 61 (2.3%) 0.935

Data are presented as number (%)

Abbreviations: DGF, delayed graft function; DSA, donor specific antigen